HTH
Hilltop Holdings Inc.
HTH's fundamentals are mixed: revenue grew only 0.2%, but its operating margin fell 2 points to 15%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
HTH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
HTH's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HTH.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
HTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $15.72 | -56% |
| Fair | 14x | $34.01 | -5.8% |
| Current | 15x | $36.10 | — |
| Forward | 16x | $36.10 | — |
| Expensive | 18x | $43.63 | +21% |
Historical ranges are pointers, not guarantees.
HTH's PE is in its fair range at 15x. On analysts' estimates for next year's earnings, today's price would be 16x, in its expensive range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
HTH Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect HTH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
HTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.23 | -7% |
| Q3 2026 | $2.40 | -4.4% |
| Q2 2026 | $2.70 | +21% |
| Q1 2026 | $2.64 | +34% |
| Q4 2025 | $2.65 | +52% |
| Q3 2025 | $2.51 | +54% |
| Q2 2025 | $2.23 | +28% |
| Q1 2025 | $1.97 | +15% |
| Q4 2024 | $1.74 | +3% |
HTH has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
HTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $309.5M | -6.3% |
| Q2 2026 | $315.8M | +4.1% |
| Q1 2026 | $300.5M | -5.6% |
| Q4 2025 | $329.9M | +9.6% |
| Q3 2025 | $330.2M | +8.1% |
| Q2 2025 | $303.3M | +2.1% |
| Q1 2025 | $318.5M | +12% |
| Q4 2024 | $301.1M | +3.7% |
HTH's revenue fell from its 2020 peak and has held roughly level since: $310M last quarter, down 6.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -7 points |
| Q2 2026 | 16% | -0.5 points |
| Q1 2026 | 17% | -1.3 points |
| Q4 2025 | 16% | +1.4 points |
| Q3 2025 | 18% | +4.5 points |
| Q2 2025 | 16% | +6.4 points |
| Q1 2025 | 18% | +4.8 points |
| Q4 2024 | 15% | +1.5 points |
HTH has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
HTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $503.6M | +86% |
| Q2 2026 | -$162.8M | +$71.7M |
| Q1 2026 | -$133.9M | -2757% |
| Q4 2025 | -$97M | -180% |
| Q3 2025 | $271M | -47% |
| Q2 2025 | -$234.6M | +$202.7M |
| Q1 2025 | $5M | -93% |
| Q4 2024 | $121.9M | -53% |
HTH has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
HTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -808K shares |
| 1 year | -8.1% | -5M shares |
| 3 years | -12% | -8M shares |
| 5 years | -29% | -23.4M shares |
| Available history | -38% | -35.3M shares |
HTH has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $20M |
| Q2 2026 | $47M |
| Q1 2026 | $47.5M |
| Q4 2025 | $60.8M |
| Q3 2025 | $55.1M |
| Q2 2025 | $34.9M |
| Q1 2025 | $33.3M |
| Q4 2024 | — |
HTH spent $175M buying back its own shares over the past year, up 42% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
HTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | -2.6x | Net Cash |
| Q2 2025 | -1.2x | Net Cash |
| Q1 2025 | -5.2x | Net Cash |
| Q4 2024 | 4.6x | High |
HTH has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like HTH.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
HTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 22.6 | Neutral |
HTH's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
HTH PE vs Financial Services Sector
| Metric | HTH | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 16% above |
| PE % | 61 | 63 | 2 pts below |
HTH is trading at 15x earnings, a 16% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
HTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.0 | 2.5% below |
| 20 week MA | $38.2 | 5.4% below |
| 50 week MA | $37.3 | 3.2% below |
| 100 week MA | $34.2 | 5.5% above |
| 200 week MA | $32.7 | 10% above |
HTH has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
HTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.6 | $27.3 | +11% |
| 2021 | $27.3 | $34.7 | +27% |
| 2022 | $34.7 | $29.7 | -14% |
| 2023 | $29.7 | $35.2 | +19% |
| 2024 | $35.2 | $28.9 | -18% |
| 2025 | $28.9 | $34.6 | +20% |
| 2026 YTD | $34.6 | $36.1 | +4.3% |
HTH has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.